News
Clinical Trials Arena on MSN11d
MSD’s subcutaneous Keytruda non-inferior to IV version of blockbuster drugCompared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda was able to reduce the time patients spent in the chemotherapy chair.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback